15 results about "Attention deficit" patented technology

1. The name of the design product: eye movement cognitive and attention assessment training instrument. 2. The use of the design product: for attention deficit groups such as hyperactivity and autism. 3. The design points of the design product: in shape. 4. The picture or photo that best indicates the design points: perspective view 1.

This application relates to a method, apparatus, and device for screening the risk of reading and attention deficit disorder in children. The method includes acquiring multi-channel raw brain blood oxygenation signals under task-induced conditions using a specific layout fNIRS array integrated into a wearable headband, based on a rapid naming cognitive paradigm. Based on the raw brain blood oxygenation signals, a fusion feature vector representing the reading and attention networks is generated by calculating temporal waveform features and frontotemporal functional connectivity strength. The multi-dimensional fusion feature vector is then processed and analyzed using a Transformer classification model to generate classification results indicating the risk level of reading disorders and comorbid ADHD. This application achieves portable and rapid brain function signal acquisition by integrating a targeted fNIRS array with a standardized cognitive paradigm. By fusing temporal dynamics and brain network connectivity features, a multi-dimensional neural representation is constructed. Finally, a lightweight Transformer model is used to output the risk level of reading disorders and comorbid ADHD end-to-end, achieving high-precision automated assisted screening.

The invention relates to a pellet as well as a preparation method and application thereof. The pellet has a treatment effect on attention deficit and attention disorder of children. The invention also provides a tablet containing the pellet, the tablet comprises active pharmaceutical ingredients and pharmaceutically acceptable auxiliary materials, and the active pharmaceutical ingredients exist in the core pellet. The pellet and the tablet containing the pellet have a good release characteristic.

The invention discloses a children attention deficit early intelligent screening system based on multi-modal behavior feature fusion. The system comprises a data acquisition module, a data processing module and a data classification judgment module. The data acquisition module is used for acquiring handwriting data, action feature data and facial expression feature data of a child; the data processing module is used for performing space-time alignment and feature level fusion on the acquired handwriting data, action feature data and facial expression feature data to obtain processed data; and the data classification and judgment module is used for carrying out classification and judgment on the processed data to obtain a screening result and finish early intelligent screening of the attention deficits of children. According to the invention, the Microsoft Surface touch device and the external camera are used for collecting the bottom data in the drawing process of children in real time, and computer vision and a machine learning algorithm are combined, so that the attention defect screening function is realized.

The invention relates to a multifunctional medicine release composition as well as a preparation method and application thereof. The multifunctional medicine release composition has a treatment effect on attention deficit and attention disorder of children. The invention also provides a dispersible sustained-release multi-unit pellet system which comprises an active pharmaceutical ingredient and pharmaceutically acceptable auxiliary materials, and the active pharmaceutical ingredient exists in the core pellet. The invention also relates to a method for preparing the sustained-release multi-unit pellet system by adopting a multi-seal coating technology. The dispersible slow-release multi-unit pellet system disclosed by the invention has a good release characteristic.

The invention relates to the technical field of screening and application of probiotics, in particular to bifidobacterium lactis HC2786 for reducing and removing harm of heavy metal in a body and application of the bifidobacterium lactis HC2786. The bifidobacterium anaticum subsp. Lactis HC2786 is preserved in the China Center for Type Culture Collection (CCTCC), the preservation number is CCTCC NO: M 20222008, and the preservation date is December 23, 2022, the preservation number is CCTCC NO: M 20222008, the preservation number is CCTCC NO: M 20222008, and the preservation number is CCTCC NO: M 20222008. The strain has a relatively strong adsorption effect on heavy metals such as mercury, silver, cadmium and chromium, is not easy to desorb, can reduce the accumulation level of various heavy metals in a central nervous system, alleviates the toxic action of the heavy metals on the nervous system, effectively improves hyperactivity, anxiety and dysphoria, spatial memory disorder, attention deficit and other hyperactivity disorder related neurological behavior abnormalities, and has a good application prospect. The method has great application value.

The invention involves novel, oral solutions of bitter drugs using Vitamin E TPGS as a masking agent and methods of using the same (e.g., for treating attention deficit / hyperactivity disorder (ADHD)). Atomoxetine (e.g., Atomoxetine HCl) is an example of a bitter drug whose bitterness can be masked by the presence of Vitamin E TPGS alone or in combination with additional ingredients.

The present invention relates a method of treating attention-deficit / hyperactivity disorder (ADHD), wherein the patient suffers from mood disorders and / or anxiety. More specifically, the present invention is directed to a method of using a carbamate compound alone or in combination with other medications, for the treatment of ADHD.

An orally disintegrating pharmaceutical tablet comprising: between 0.1 and 21 wt % of cariprazine or its pharmaceutically acceptable salts, between 0.1 and 15 wt % of a disintegrant, between 0.1 and 5 wt % of colloidal silicon dioxide, between 0.1 and 10 wt % of a taste masking agent, between 0.1 and 5 wt % of a lubricant, and up to 100 wt % of a diluent, the percentage being expressed with regard to the total weight of the pharmaceutical tablet. Said composition for use in the treatment and / or prevention of pathological conditions which require the modulation of dopamine receptors, selected from the group of psychoses, drug abuse, cognitive impairment accompanying schizophrenia, mild-to-moderate cognitive deficits, dementia, psychotic states associated with dementia, eating disorders, attention deficit disorders, hyperactivity disorders in children, psychotic depression, bipolar disorder, paranoid and delusional disorders, dyskinetic disorders, anxiety, sexual dysfunction, sleep disorders, emesis, aggression and autism.

The invention discloses a child attention deficit test method integrating a gamification task, and relates to the technical field of child physical examination, and the method comprises the steps: presenting a series of interactive digital games with cognitive load to a tested individual by using a self-adaptive task generation engine; behavior response signals, physiological electric signals and kinematics signals generated in the process that the individuals participate in the interactive digital game are synchronously collected; calculating a dynamic cognitive state vector of the individual in real time according to the collected signals; and performing conjoint analysis on difficulty parameters adopted by the whole series of interactive digital games and dynamic cognitive state vectors fed back by the difficulty parameters to generate a final test report. According to the method, the defects of high subjectivity, single data and the like of a traditional evaluation method are effectively overcome through fusion of the self-adaptive game task and the multi-modal data; by capturing the dynamic change of the cognitive state of the child in real time, personalized accurate evaluation is realized.

The invention discloses an ADHD and subtype diagnosis method based on a deep network. The ADHD and subtype diagnosis method based on the deep network comprises the following steps: establishing a sight tracking network CognittionNet; the method comprises the following steps: acquiring an attention signal At (t) and an iris signal Ir (t) by using a front short video input CognittionNet of a person to be detected; the variance (Atstd) and the average change speed (Atvmean) of At (t) are counted; counting the average change speed (Irvmean) of the Ir (t); judging whether the person to be detected is ADHD or non-ADHD; and judging and confirming whether the ADHD patient belongs to an attention deficit type (ADHD-I), a hyperactivity impulse type (ADHD-II) or a hybrid type (ADHD-III). Therefore, the objective diagnosis of the ADHD and the subtype thereof can be realized by only adopting one short video.

The present invention provides aceclofenac, amlodipine or doxazosin, or a pharmaceutically acceptable salt or solvate thereof, for use in the treatment or prophylaxis of Attention Deficit / Hyperactivity Disorder (ADHD). The invention also provides kits and methods for the treatment or prophylaxis of ADHD.

Disclosed herein are methods of treating attention deficit / hyperactivity disorder (ADHD), major depressive disorder (MDD), binge eating disorder (BED), or shift work disorder (SWD) in a human, such as an adult, by administering safinamide to a human having ADHD, MDD, BED, or SWD. Safinamide can be administered in the morning, such as within one hour of waking. In some embodiments, safinamide is administered more than 9 hours before the expected bedtime.

The present invention provides a method for treating a subject with attention deficit by selecting the position of a corrective coordinate in a device including at least one lens, wherein the corrective coordinate is within the subject's field of vision when the subject wears the device, or by converting eyeglasses into a device to improve the function of a subject with attention deficit. The method involves positioning a corrective element at a predetermined location on at least one lens, wherein the position of the corrective element lies within a defined corrective region having the shape of a two-dimensional double arc.